Wells Fargo Maintains Overweight on Oscar Health, Raises Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter maintains an Overweight rating on Oscar Health (NYSE:OSCR) and raises the price target from $8.5 to $12.
June 13, 2023 | 12:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo maintains an Overweight rating on Oscar Health and raises the price target from $8.5 to $12.
The news of Wells Fargo maintaining an Overweight rating on Oscar Health and raising the price target from $8.5 to $12 indicates a positive outlook for the company's stock. This could lead to an increase in investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100